WASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive its antitrust lawsuit accusing rival pharmaceutical company Viatris Inc of illegally monopolizing ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ADRENALINE VIATRIS contains the active ingredient adrenaline ...
Sanofi claimed Viatris (formerly Mylan) used rebates to pharmacy benefit managers to secure monopoly A 10th Circuit panel said negotiating exclusivity for lower consumer prices was legal (Reuters) - ...
Viatris Inc (NASDAQ:VTRS) saw its stock increase by 2.6% after the U.S. Food and Drug Administration approved its Iron Sucrose Injection, USP, marking the first generic alternative to Venofer® ...
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Viatris Inc. is one of them. Viatris Inc. (NASDAQ:VTRS), formed from the 2020 merger of Mylan ...
Approval Granted with Competitive Generic Therapy Eligibility for 100mg/5mL and 200mg/10mL Strengths; Provides Eligibility for 180 Days of Exclusivity Viatris Chief R&D Officer Philippe Martin said, ...
Zacks Investment Research on MSN
Viatris gets FDA nod for generic Sandostatin, shares regulatory updates
Viatris Inc. VTRS recently announced four regulatory achievements across multiple stages of its pipeline. These achievements ...
WASHINGTON, April 17 (Reuters) - The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA (SASY.PA), opens new tab to revive its antitrust lawsuit accusing rival pharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback